SCHEMBL4871805

SCHEMBL4871805

Cc1ccccc1CC1(N(C)C)CCC(NC(=O)C(Cc2ccccc2)NC(=O)OCc2ccccc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CTSL P07711 7/20 0.50
CTSK P43235 7/20 0.48
CTSB P07858 5/20 0.48
CTSS P25774 4/20 0.48
TACR1 P25103 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4868422 0.89 CYP1A2 (0.48) CTSLCTSKCTSBCTSS
SCHEMBL4867960 0.89 SCN9A (0.49) CTSLCTSKCTSBCTSS
SCHEMBL4861839 0.88 CTSL (0.48) CTSLCTSS
SCHEMBL4865108 0.84 CTSK (0.49) CTSLCTSKCTSBCTSS
SCHEMBL4865149 0.80 ALDH1A1 (0.45) CTSLCTSKCTSBCTSS
SCHEMBL4868448 0.80 CYP1A2 (0.50) CTSLCTSKCTSBCTSS
SCHEMBL4864055 0.79 SCN9A (0.49) CTSLCTSKCTSBCTSS
SCHEMBL4867952 0.79 CTSS (0.51) CTSLCTSKCTSBCTSS
SCHEMBL4868278 0.79 SCN9A (0.53) CTSLCTSKCTSBCTSS
SCHEMBL4871921 0.78 CTSL (0.47) CTSLCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751090-B1 ACID DERIVATIVES OF SUBSTITUTED CYCLOHEXYL-1,4-DIAMINES GRUENENTHAL GMBH (DE) 2014-10-08 EP claimed
US-7439394-B2 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2008-10-21 US claimed
US-20070117803-A1 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-24 US claimed
US-7439394-B2 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2008-10-21 US disclosed
US-20070117803-A1 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117803-A1 Cyclohexyl-1,4-diamine compounds PKD1, DDC, DPYD CTSL 2008/4885CTSK 1123/4885CTSB 1132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.